Cohen Jacob D. 13D and 13G filings for Mangoceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-27 7:45 pm Purchase | 2024-08-26 | 13D | Mangoceuticals, Inc. MGRX | Cohen Jacob D. | 721,667 34.200% | 16,667 (+2.36%) | Filing |
| 2024-06-05 5:15 pm Purchase | 2024-06-03 | 13D | Mangoceuticals, Inc. MGRX | Cohen Jacob D. | 705,000 34.700% | 53,333 (+8.18%) | Filing |
| 2023-12-29 9:51 pm Purchase | 2023-12-28 | 13D | Mangoceuticals, Inc. MGRX | Cohen Jacob D. | 651,667 42.600% | 100,000 (+18.13%) | Filing |
| 2023-05-02 8:55 pm Purchase | 2023-04-10 | 13D | Mangoceuticals, Inc. MGRX | Cohen Jacob D. | 551,667 47.800% | 551,667 (New Position) | Filing |